Daniel M. Geynisman, Philip H. Abbosh, Eric Ross, Matthew R. Zibelman, Pooja Ghatalia, Fern Anari, James R. Mark, Lambros Stamatakis, Jean H. Hoffman-Censits, Rosalia Viterbo, Richard E. Greenberg, Thomas M. Churilla, Eric M. Horwitz, Mark A. Hallman, Marc C. Smaldone, Robert Uzzo, David Y.T. Chen, Alexander Kutikov, Elizabeth R. Plimack. "Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)." Journal of Clinical Oncology, 2025. doi:10.1200/jco-24-01214